tazobactam has been researched along with alanine in 2 studies
| Studies (tazobactam) | Trials (tazobactam) | Recent Studies (post-2010) (tazobactam) | Studies (alanine) | Trials (alanine) | Recent Studies (post-2010) (alanine) |
|---|---|---|---|---|---|
| 1,327 | 153 | 694 | 24,468 | 512 | 5,581 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bonomo, RA; Carey, MP; Carey, PR; Helfand, MS; Hujer, AM; Padayatti, PS; Totir, MA; van den Akker, F | 1 |
| Bethel, CR; Bonomo, RA; Knox, JR; Sun, T | 1 |
2 other study(ies) available for tazobactam and alanine
| Article | Year |
|---|---|
Tazobactam forms a stoichiometric trans-enamine intermediate in the E166A variant of SHV-1 beta-lactamase: 1.63 A crystal structure.
Topics: Acylation; Alanine; beta-Lactamase Inhibitors; beta-Lactamases; Binding Sites; Crystallography, X-Ray; Glutamic Acid; Models, Molecular; Molecular Conformation; Penicillanic Acid; Recombinant Proteins; Spectrum Analysis, Raman; Tazobactam | 2004 |
Inhibitor-resistant class A beta-lactamases: consequences of the Ser130-to-Gly mutation seen in Apo and tazobactam structures of the SHV-1 variant.
Topics: Alanine; Amino Acid Substitution; Apoenzymes; beta-Lactam Resistance; beta-Lactamase Inhibitors; beta-Lactamases; Binding Sites; Catalysis; Crystallography, X-Ray; Enzyme Inhibitors; Escherichia coli Proteins; Genetic Variation; Glutamic Acid; Glycine; Hydrolysis; Models, Molecular; Mutagenesis, Site-Directed; Penicillanic Acid; Serine; Tazobactam | 2004 |